Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism
2017 Science
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Classification and Grading of Gastritis
1996 Standout
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
1999
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network
2007
Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis
2003
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
2012 Standout
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome?
2007
Hepatocellular carcinoma
2018 Standout
Design of Clinical Trials Evaluating Dietary Interventions in Patients With Functional Gastrointestinal Disorders
2013
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Budd–Chiari syndrome: a review by an expert panel
2003
Role of cellular senescence in hepatic wound healing and carcinogenesis
2012
Molecular targeted therapies in hepatocellular carcinoma†
2008
Long-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome
2006
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres
2005
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
Experimental models of hepatocellular carcinoma
2008
Antithrombotic Therapy for VTE Disease
2016 Standout
Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis
2007
Mast cells: an expanding pathophysiological role from allergy to other disorders
2012
Hepatocellular carcinoma
2012 Standout
IgE and mast cells in allergic disease
2012 Standout
Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis
2007
Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver Disease
2007
Hepatocellular carcinoma
2021 Standout
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy
2002
Telomeres and telomerase: A dual role in hepatocarcinogenesis
2004
Telomerase Antagonists GRN163 and GRN163L Inhibit Tumor Growth and Increase Chemosensitivity of Human Hepatoma *
2005
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
2015
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
2004 Standout
Vascular disorders of the liver # †
2008 Standout
Fibromuscular Dysplasia
2004 Standout
High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome
2005
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
2007 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia
2008
Antithrombotic Therapy for VTE Disease
2012 Standout
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis†
2007
Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication
2006
Inflammation and Colon Cancer
2010 Standout
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders
2007
Hereditary Hemorrhagic Telangiectasia: Multi–Detector Row Helical CT Assessment of Hepatic Involvement
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
2006
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Liver transplantation for budd-chiari syndrome
2002
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study
2008
Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis
2015
Epsilon germ‐line and IL‐4 transcripts are expressed in human intestinal mucosa and enhanced in patients with food allergy
2005
Role of TIPS as a Bridge to Hepatic Transplantation in Budd-Chiari Syndrome
1999
Contemporary imaging techniques for the diagnosis of renal artery stenosis
2005
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
2006
Intervention for renal artery stenosis: endovascular and surgical roles
2005
Liver Disease in Patients with Hereditary Hemorrhagic Telangiectasia
2000
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
2003
Parenchymal consequences of fibromuscular dysplasia renal artery stenosis
2002
Reassessing the role of medical therapy in the management of hepatic vein thrombosis
1997
The role of telomeres and telomerase in cirrhosis and liver cancer
2019
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Is duplex scanning the best screening test for renal artery stenosis?
2001
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
2005
Atherosclerotic renal artery disease
2002
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Repeat Interventions for Maintenance of Transjugular Intrahepatic Portosystemic Shunt Function in Patients with Budd-Chiari Syndrome
2002
AGA technical review on irritable bowel syndrome
2002 Standout
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
2007
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Hepatocellular Carcinoma
2011 Standout
Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations
2006
Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review
2005
Budd-Chiari Syndrome: Current Management Options
2001
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Budd–Chiari syndrome: Long‐term effect on outcome with transjugular intrahepatic portosystemic shunt
2005
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
Primary sclerosing cholangitis – a comprehensive review
2017
Cellular senescence: from physiology to pathology
2014 Standout
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
2005
Irritable Bowel Syndrome
2015 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century
2003
Colonic Eosinophilic Inflammation in Experimental Colitis Is Mediated by Ly6Chigh CCR2+ Inflammatory Monocyte/Macrophage-Derived CCL11
2011
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Liver Involvement in Hereditary Hemorrhagic Telangiectasia: CT and Clinical Findings Do Not Correlate in Symptomatic Patients
2006
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
1995
Progressive Hypertension in a Patient With “Incidental” Renal Artery Stenosis
2002
Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure
2002
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Increased mast cells in the irritable bowel syndrome
2000
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Subepithelial hemorrhages and erosions of human stomach
1988
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
2013
Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review
2006
Optimized contrast‐enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single‐center retrospective study
2014
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment
2009
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari Syndrome or portal vein thrombosis Review of indications and problems
1999
Renal Atrophy Outcome after Revascularization in Fibromuscular Dysplasia Disease
2002
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of M Gebel being referenced
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy.
1997
Which is the best surgery for budd-chiari syndrome: Venous decompression or liver transplantation? a single-center experience with 50 patients
1995
Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography—A prospective study
2011
Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis
2014
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
1996
Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma
2004
Hepatocellular carcinoma and octreotide: Treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage
2005
Interobserver Agreement in Diagnosing Liver Involvement in Hereditary Hemorrhagic Telangiectasia by Doppler Ultrasound
2008
Surgical removal of a distinct subcutaneous metastasis of multilocular hepatocellular carcinoma 2 months after initial percutaneous ethanol injection therapy
2001
Use of Doppler Ultrasonography to Predict the Outcome of Therapy for Renal-Artery Stenosis
2001
T-Cell Lymphoma after Heart Transplantation
1990
Sonographic Criteria for the Diagnosis of Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia (Hht)
2003
Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease)
1998
Telomere Shortening Correlates With Increasing Aneuploidy of Chromosome 8 in Human Hepatocellular Carcinoma *
2005
Follow-up Study of Chronic Gastric Erosions
1979
Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma
2004
Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure.
2000
A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma: Final results
2007